BioSpace News Archive

Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders, announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 10,400,000 shares

MiMedx Group, Inc. (NASDAQ: MDXG) (“MiMedx” or the “Company”), an industry leader in advanced wound care and a therapeutic biologics company, today announced the appointment of Jack Howarth as Senior Vice President of Investor Relations

Limitless Venture Group, Inc. (“LVGI” or “the Company”) today announced it has acquired the majority interest in Jasper Benefit Solutions LLC, an MGU, through an equity and capitalization agreement.

Cellaria Inc (Wakefield, MA, USA) and the Spring Lab, Northeastern University, announce the successful receipt of a National Institutes of Health (NIH) R01 grant to extend and advance the application of innovative new photomedicine-based therapies for hard-to-treat cancers. The grant highlights the close working relationshi

New Orders and Production Growing; Employment Contracting; Supplier Deliveries Slowing at Faster Rate; Backlog Growing; Raw Materials Inventories Growing; Customers’ Inventories Too Low; Prices Increasing; Exports and Imports Growing

Dragonfly Therapeutics, Inc. (“Dragonfly”), today announced that Merck, known as MSD outside the United States and Canada , has licensed its first TriNKET™ immunotherapy candidate from Dragonf

Aya Healthcare, the digitally driven travel nurse staffing and healthcare workforce solutions company that’s transformed the healthcare staffing industry across the United States , was selected by Modern Healthcare and its judges as an award winner in the 2020 Healthcare Marketing Impact Awards. Aya’s Nurses Week Video Campaign was

Company’s first specialty drug is therapeutically equivalent to Firazyr ® and is a cost-effective generic alternative to currently marketed products for the treatment of acute attacks of hereditary angioedema Fresenius Kabi launches KabiCare patient support program in U.S. to promote access to essential medications

The preclinical research demonstrates that combining the oncolytic virus CF33 with an immune checkpoint inhibitor results in lasting resistance to certain tumors

OptaSensor now released the smallest commercially available digital camera, with high resolution, just 1x1mm in size and a volume of 1,7mm³ only.